AP1S1

Chr 7AR

adaptor related protein complex 1 subunit sigma 1

Also known as: AP19, CLAPS1, EKV3, MEDNIK, SIGMA1A

The protein encoded by this gene is part of the clathrin coat assembly complex which links clathrin to receptors in coated vesicles. These vesicles are involved in endocytosis and Golgi processing. This protein, as well as beta-prime-adaptin, gamma-adaptin, and the medium (mu) chain AP47, form the AP-1 assembly protein complex located at the Golgi vesicle. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.861 OMIM phenotype
Clinical SummaryAP1S1
🧬
Gene-Disease Validity (ClinGen)
MEDNIK syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 20 VUS of 162 total submissions
📖
GeneReview available — AP1S1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.86LOEUF
pLI 0.100
Z-score 1.85
OE 0.33 (0.150.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.74Z-score
OE missense 0.47 (0.370.61)
41 obs / 86.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.33 (0.150.86)
00.351.4
Missense OE?0.47 (0.370.61)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 3 / 9.0Missense obs/exp: 41 / 86.7Syn Z: 0.40

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.6638th %ile
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

162 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic6
VUS20
Likely Benign104
Benign21
Conflicting2
4
Pathogenic
6
Likely Pathogenic
20
VUS
104
Likely Benign
21
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
1
0
4
Likely Pathogenic
6
0
0
0
6
VUS
1
19
0
0
20
Likely Benign
0
0
56
48
104
Benign
0
0
16
5
21
Conflicting
2
Total10197353157

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 28) ClinVar copy-number / structural variants overlap AP1S1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

AP1S1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →